EUVIMEDEUVIMED entdecken
Crossref

Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease

J Bae, Y Cho, J-Y Kim, J-J Yim, N Kwak

The International Journal of Tuberculosis and Lung Disease · 27.03.2026 · 30 (4) · 161-166

DOI: 10.5588/ijtld.25.0407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 27.03.2026. Verfasst von J Bae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National Univ…. Hauptthemen laut MEDLINE: Mycobacterium avium-intracellulare Infection, Mycobacterium avium Complex, Anti-Bacterial Agents, Lung Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

This study aimed to investigate the trends in treatment patterns and outcomes over the past 15 years among patients with Mycobacterium avium complex pulmonary disease (MAC-PD) treated at a tertiary hospital in South Korea.





METHODS

Patients with newly diagnosed MAC-PD, who were treated at Seoul National University Hospital between 1 January 2011 to 31 August 2024, were categorised into three groups according to the date of initial treatment: group 1 (2011–2015), group 2 (2016–2020), and group 3 (2021–2024). Changes in patient characteristics, treatment patterns, and clinical outcomes were analysed.





RESULTS

A total of 624 patients were included (141, 240, and 243 in groups 1, 2, and 3, respectively). While the use of rifampicin declined, the use of azithromycin, inhaled or intravenous amikacin, and clofazimine increased over time. The probability of culture conversion progressively improved (Tarone–Ware test, P < 0.001), and the microbiological cure rate increased from 39.0% in group 1 to 49.2% and 61.8% in groups 2 and 3, respectively ( P for trend < 0.001).





CONCLUSION

Since 2011, treatment strategies for MAC-PD have evolved toward a more proactive approach, accompanied by a gradual improvement in treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium-intracellulare InfectionMycobacterium avium ComplexAnti-Bacterial AgentsLung DiseasesAntitubercular AgentsHumansRepublic of KoreaTreatment OutcomeFemaleMaleAgedMiddle AgedRetrospective StudiesTime FactorsRifampinTertiary Care Centers

Substanzen

Anti-Bacterial AgentsAntitubercular AgentsRifampin

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea;, Department of Microbiology, Harvard Medical School, Boston, MA, USA.

Zitieren

APA

Bae, J., Cho, Y., Kim, J. Y., Yim, J. J., & Kwak, N. (2026). Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease. The International Journal of Tuberculosis and Lung Disease, 30(4), 161-166. https://doi.org/10.5588/ijtld.25.0407

Vancouver

Bae J, Cho Y, Kim JY, Yim JJ, Kwak N. Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease. The International Journal of Tuberculosis and Lung Disease. 2026;30(4):161-166. doi:10.5588/ijtld.25.0407

BibTeX
@article{Bae2026,
  author = {Bae, J and Cho, Y and Kim, J-Y and Yim, J-J and Kwak, N},
  title = {Temporal trends in treatment strategies and outcomes of newly diagnosed Mycobacterium avium complex pulmonary disease},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {161--166},
  doi = {10.5588/ijtld.25.0407}
}
Kostenlos starten →